A nationwide multicentre study led by the Marqués de Valdecilla University Hospital demonstrates that lung transplantation is a safe and effective option in patients with advanced pneumoconiosis — mainly silicosis — an irreversible lung disease caused by prolonged inhalation of silica dust. The work has been published in the international scientific journal Respirology and is […]
The Marqués de Valdecilla University Hospital held a theoretical‑practical course focused on the management of multiple myeloma and innovative anti‑BCMA immunotherapy strategies, bringing together Hematology specialists to address the latest advances in diagnosis, treatment, and clinical practice. Organized by the hospital’s Hematology and Hemotherapy Department, the training program aimed primarily to update knowledge on one […]
The Valdecilla Virtual Hospital, in collaboration with the Hematology Department of the Marqués de Valdecilla University Hospital, is organizing the course “Management of Immunotherapy in Acute Lymphoblastic Leukemia (ALL)” on May 13 and 14. This advanced training program is aimed at pediatric onco‑hematologists and hematologists interested in this disease. The activity has the institutional support […]
The Valdecilla Health Research Institute (IDIVAL) has opened the call for the 2026 Competitive Intensification Program, which will remain open until May 15. This program aims to temporarily relieve healthcare professionals with a high research or innovation workload, allowing them to dedicate themselves fully to research projects or the development of new clinical techniques and […]
The Valdecilla Health Research Institute (IDIVAL) has launched the project “Boosting Internationalization and the Management of European Health Projects in Cantabria”, a strategic initiative aimed at strengthening its positioning within the Horizon Europe framework programme and consolidating its leadership in securing and managing European R&D&I funding. The project is being developed within the call for […]
This morning’s session of the Santander Biomedical Lectures program, organized by the Marqués de Valdecilla Research Institute (IDIVAL), featured a presentation by researcher Adolfo García-Sastre, who delivered a lecture titled “A vaccine platform based on avian paramyxovirus / Una plataforma vacunal basada en paramixovirus de aves.” During his talk, the expert outlined the development of […]
Summary: The joint action Hope4Kids – Comprehensive Oncological Palliative Care for the Children of Europe” aims to strengthen and harmonize pediatric palliative care (PPC) across Europe for all children living with life‑threatening or life‑limiting conditions. Across Europe, many children suffer from severe, complex, or rare chronic illnesses that significantly affect their quality of life and, […]
The conference “Discover research and what IDIVAL offers” focused on bringing biomedical research closer to first-year residents through a practical and accessible approach. Within this framework, the Valdecilla Biobank played a leading role during key presentations by María José Marín, scientific director and Inés Santiuste, coordinator of the DNA and fluids node. Their message to […]
The Fila 0 (Row 0) remains open for those wishing to collaborate with the project promoted by IDIVAL and enter the draw for an official jersey signed by the Legends. The Valdecilla Research Institute (IDIVAL) has expressed a very positive assessment of the charity match held last Saturday at the La Ribera field in Suances, […]
The Marqués de Valdecilla Research Institute (IDIVAL) has published the Preview of its 2025 Activity Report, a document that highlights the main achievements in biomedical research, innovation, and knowledge transfer carried out over the past year. The IDIVAL, accredited as a Health Research Institute since 2015 and reaccredited in 2025, continues to consolidate its position […]
Biomedical research and innovation are only possible thanks to everyone’s collaboration. This is how we move forward in improving the health of patients and the wider community